Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Ordinary Shares, no par value
-
Shares outstanding
-
3,838,602,439
-
Total 13F shares
-
114,427
-
Share change
-
-664,992
-
Total reported value
-
$185,941
-
Price per share
-
$1.62
-
Number of holders
-
13
-
Value change
-
-$1,330,864
-
Number of buys
-
2
-
Number of sells
-
4
Institutional Holders of Can-Fite BioPharma Ltd. - Ordinary Shares, no par value (CANF) as of Q4 2024
As of 31 Dec 2024,
Can-Fite BioPharma Ltd. - Ordinary Shares, no par value (CANF) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
114,427 shares.
The largest 10 holders included
MORGAN STANLEY, RHUMBLINE ADVISERS, BNP PARIBAS FINANCIAL MARKETS, TWO SIGMA SECURITIES, LLC, Kohmann Bosshard Financial Services, LLC, FIFTH THIRD BANCORP, WELLS FARGO & COMPANY/MN, NATIONAL BANK OF CANADA /FI/, CITIGROUP INC, and Activest Wealth Management.
This page lists
13
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.